ZSAN

Zosano Pharma CorpCIK 1587221 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for ZSAN PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for ZSAN

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Matthews Christine	Chief Financial Officer	10	$0	$3.1K	2022-06-06
Lo Steven	Chief Executive Officer	11	$0	$15.9K	2022-06-06
KELLERMAN DONALD J	VP, Clinical Dev & Med Affairs	16	$25.2K	$2.2K	2022-03-31
Yang Elaine	Director	1	$0	$0	2021-12-07
GREATHOUSE KENNETH	Director	15	$123.5K	$6.0K	2021-11-23
Hagan Joseph P	Director	9	$0	$0	2021-06-10
Grais Linda S	Director	6	$0	$0	2021-06-10
XANTHOPOULOS KLEANTHIS G	Director	12	$25.2K	$0	2021-06-10
ELMS STEVE	Director, 10% Owner	7	$0	$0	2021-06-10
Lewis Hayley	VP, Reg Affairs & Quality	13	$7.5K	$1.4K	2021-06-04
McGee Kathy M.	Director	1	$0	$0	2021-05-24
WALKER JOHN PETER	President and CEO	20	$650.5K	$0	2020-06-25
Aisling Capital Partners IV LLC	10% Owner	1	$0	$0	2019-12-02
Kitchener Gregory David	Chief Financial Officer	4	$0	$0	2019-06-11
WILSON TROY EDWARD	Director	5	$0	$0	2019-01-02
Kazma Gerald J	10% Owner	3	$0	$741.4K	2018-02-27
Erbez Georgia	Interim CFO	5	$165.2K	$0	2017-05-25
Tso Winnie Wing-Kei	Chief Financial Officer	3	$0	$0	2017-04-10
Alataris Konstantinos	President, CEO	13	$201.3K	$0	2017-03-20
NEA 12 GP, LLC	10% Owner	4	$0	$2.24M	2017-02-13
BARRETT M JAMES	Director, 10% Owner	14	$258.0K	$2.32M	2017-02-13
SANDELL SCOTT D	10% Owner	1	$0	$5.6K	2016-09-16
NEA Partners 12, Limited Partnership	10% Owner	2	$0	$23.5K	2016-09-13
BASKETT FOREST	10% Owner	2	$0	$52.0K	2016-08-29
Scharin Eric	VP, Engineering & Operations	1	$0	$0	2016-06-30
Peri Laxmi	Sr. Vice President, Operations	3	$0	$0	2015-12-15
DRANT RYAN D	10% Owner	5	$258.0K	$0	2015-01-30
BioMed Realty L P	10% Owner	8	$292.0K	$0	2015-01-30

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Lo Steven	Chief Executive Officer	S Sale	2022-06-06	2022-06-07	442	$0.71	$314	13,163	SEC↗
Matthews Christine	Chief Financial Officer	S Sale	2022-06-06	2022-06-07	82	$0.71	$58	4,183	SEC↗
Lo Steven	Chief Executive Officer	S Sale	2022-03-31	2022-04-01	23,633	$0.21	$5.0K	460,709	SEC↗
KELLERMAN DONALD J	VP, Clinical Dev & Med Affai	S Sale	2022-03-31	2022-04-01	4,006	$0.21	$841	56,331	SEC↗
Matthews Christine	Chief Financial Officer	S Sale	2022-03-31	2022-04-01	8,116	$0.21	$1.7K	146,425	SEC↗
Yang Elaine	Director	A Award deriv	2021-12-07	2021-12-09	90,000	—	$0	90,000	SEC↗
GREATHOUSE KENNETH	Director	S Sale	2021-11-23	2021-11-24	10,000	$0.60	$6.0K	43,500	SEC↗
Lo Steven	Chief Executive Officer	A Award deriv	2021-10-15	2021-10-19	237,500	—	$0	237,500	SEC↗
Matthews Christine	Chief Financial Officer	A Award deriv	2021-10-15	2021-10-19	112,500	—	$0	112,500	SEC↗
KELLERMAN DONALD J	VP, Clinical Dev & Med Affai	A Award deriv	2021-10-15	2021-10-19	20,000	—	$0	20,000	SEC↗
Lo Steven	Chief Executive Officer	A Award	2021-10-15	2021-10-19	118,750	—	$0	484,342	SEC↗
Matthews Christine	Chief Financial Officer	A Award	2021-10-15	2021-10-19	56,250	—	$0	154,541	SEC↗
KELLERMAN DONALD J	VP, Clinical Dev & Med Affai	A Award	2021-10-15	2021-10-19	10,000	—	$0	60,337	SEC↗
Hagan Joseph P	Director	A Award deriv	2021-06-10	2021-06-14	30,000	—	$0	30,000	SEC↗
XANTHOPOULOS KLEANTHIS G	Director	A Award deriv	2021-06-10	2021-06-14	30,000	—	$0	30,000	SEC↗
GREATHOUSE KENNETH	Director	A Award deriv	2021-06-10	2021-06-14	30,000	—	$0	30,000	SEC↗
ELMS STEVE	Director	A Award deriv	2021-06-10	2021-06-14	30,000	—	$0	30,000	SEC↗
Grais Linda	Director	A Award deriv	2021-06-10	2021-06-14	30,000	—	$0	30,000	SEC↗
Hagan Joseph P	Director	A Award	2021-06-10	2021-06-14	15,000	—	$0	22,500	SEC↗
XANTHOPOULOS KLEANTHIS G	Director	A Award	2021-06-10	2021-06-14	15,000	—	$0	23,596	SEC↗
GREATHOUSE KENNETH	Director	A Award	2021-06-10	2021-06-14	15,000	—	$0	53,500	SEC↗
ELMS STEVE	Director	A Award	2021-06-10	2021-06-14	15,000	—	$0	22,500	SEC↗
Grais Linda	Director	A Award	2021-06-10	2021-06-14	15,000	—	$0	22,500	SEC↗
Matthews Christine	Chief Financial Officer	S Sale	2021-06-04	2021-06-07	1,709	$0.81	$1.4K	98,291	SEC↗
KELLERMAN DONALD J	VP, Clinical Dev & Med Affai	S Sale	2021-06-04	2021-06-07	1,709	$0.81	$1.4K	50,337	SEC↗
Lewis Hayley	See Remarks	S Sale	2021-06-04	2021-06-07	1,709	$0.81	$1.4K	49,779	SEC↗
Lo Steven	Chief Executive Officer	S Sale	2021-06-04	2021-06-07	13,158	$0.81	$10.7K	365,592	SEC↗
McGee Kathy M.	Director	A Award deriv	2021-05-24	2021-05-25	90,000	—	$0	90,000	SEC↗
GREATHOUSE KENNETH	Director	A Award	2021-05-17	2021-05-18	21,000	$0.73	$15.3K	38,500	SEC↗
Matthews Christine	Chief Financial Officer	A Award deriv	2021-03-30	2021-04-01	162,500	—	$0	162,500	SEC↗
KELLERMAN DONALD J	VP, Clinical Dev & Med Affai	A Award deriv	2021-03-30	2021-04-01	65,000	—	$0	65,000	SEC↗
Lewis Hayley	See Remarks	A Award deriv	2021-03-30	2021-04-01	65,000	—	$0	65,000	SEC↗
Lo Steven	Chief Executive Officer	A Award deriv	2021-03-30	2021-04-01	465,000	—	$0	465,000	SEC↗
Matthews Christine	Chief Financial Officer	A Award	2021-03-30	2021-04-01	81,250	—	$0	100,000	SEC↗
KELLERMAN DONALD J	VP, Clinical Dev & Med Affai	A Award	2021-03-30	2021-04-01	32,500	—	$0	52,046	SEC↗
Lewis Hayley	See Remarks	A Award	2021-03-30	2021-04-01	32,500	—	$0	51,488	SEC↗
Lo Steven	Chief Executive Officer	A Award	2021-03-30	2021-04-01	232,500	—	$0	378,750	SEC↗
Lo Steven	Chief Executive Officer	A Award deriv	2021-03-18	2021-03-19	450,000	—	$0	450,000	SEC↗
ELMS STEVE	Director	A Award	2020-06-25	2020-06-29	7,500	—	$0	7,500	SEC↗
Matthews Christine	Chief Financial Officer	A Award	2020-06-25	2020-06-29	18,750	—	$0	18,750	SEC↗
KELLERMAN DONALD J	VP, Clinical Dev & Med Affai	A Award	2020-06-25	2020-06-29	18,750	—	$0	19,546	SEC↗
Lewis Hayley	See Remarks	A Award	2020-06-25	2020-06-29	18,750	—	$0	18,988	SEC↗
WALKER JOHN PETER	Director	A Award	2020-06-25	2020-06-29	7,500	—	$0	116,511	SEC↗
Hagan Joseph P	Director	A Award	2020-06-25	2020-06-29	7,500	—	$0	7,500	SEC↗
XANTHOPOULOS KLEANTHIS G	Director	A Award	2020-06-25	2020-06-29	7,500	—	$0	8,596	SEC↗
Lo Steven	Chief Executive Officer	A Award	2020-06-25	2020-06-29	146,250	—	$0	146,250	SEC↗
Grais Linda S	Director	A Award	2020-06-25	2020-06-29	7,500	—	$0	7,500	SEC↗
GREATHOUSE KENNETH	Director	A Award	2020-06-25	2020-06-29	7,500	—	$0	17,500	SEC↗
Matthews Christine	Chief Financial Officer	A Award deriv	2020-06-03	2020-06-05	37,500	—	$0	37,500	SEC↗
KELLERMAN DONALD J	VP, Clinical Dev & Med Affai	A Award deriv	2020-06-03	2020-06-05	37,500	—	$0	37,500	SEC↗
Lewis Hayley	See Remarks	A Award deriv	2020-06-03	2020-06-05	37,500	—	$0	37,500	SEC↗
Hagan Joseph P	Director	A Award deriv	2020-06-03	2020-06-05	15,000	—	$0	15,000	SEC↗
GREATHOUSE KENNETH	Director	A Award deriv	2020-06-03	2020-06-05	15,000	—	$0	15,000	SEC↗
XANTHOPOULOS KLEANTHIS G	Director	A Award deriv	2020-06-03	2020-06-05	15,000	—	$0	15,000	SEC↗
Grais Linda S	Director	A Award deriv	2020-06-03	2020-06-05	15,000	—	$0	15,000	SEC↗
Grais Linda S	Director	A Award deriv	2020-06-03	2020-06-05	15,000	—	$0	15,000	SEC↗
ELMS STEVE	Director	A Award deriv	2020-06-03	2020-06-05	15,000	—	$0	15,000	SEC↗
Lo Steven	Chief Executive Officer	A Award deriv	2020-06-03	2020-06-05	292,500	—	$0	292,500	SEC↗
WALKER JOHN PETER	Director	A Award deriv	2020-06-03	2020-06-05	15,000	—	$0	15,000	SEC↗
Matthews Christine	Chief Financial Officer	A Award deriv	2020-05-01	2020-05-05	35,000	—	$0	35,000	SEC↗
Aisling Capital Partners IV LL	10% Owner	A Award	2019-12-02	2019-12-06	689,655	$1.45	$1000.0K	2,718,226	SEC↗
Lo Steven	Chief Executive Officer	A Award deriv	2019-10-21	2019-10-23	450,000	—	$0	450,000	SEC↗
Lewis Hayley	See Remarks	A Award deriv	2019-06-11	2019-06-13	30,000	—	$0	30,000	SEC↗
KELLERMAN DONALD J	VP, Clinical Dev & Med Affai	A Award deriv	2019-06-11	2019-06-13	30,000	—	$0	30,000	SEC↗
Kitchener Gregory David	Chief Financial Officer	A Award deriv	2019-06-11	2019-06-13	45,000	—	$0	45,000	SEC↗
Lewis Hayley	See Remarks	A Award deriv	2019-06-11	2019-06-19	30,000	—	$0	30,000	SEC↗
KELLERMAN DONALD J	VP, Clinical Dev & Med Affai	A Award deriv	2019-06-11	2019-06-19	30,000	—	$0	30,000	SEC↗
Kitchener Gregory David	Chief Financial Officer	A Award deriv	2019-06-11	2019-06-19	45,000	—	$0	45,000	SEC↗
ELMS STEVE	10% Owner	A Award	2019-04-11	2019-04-12	428,571	$3.50	$1.50M	2,028,571	SEC↗
WALKER JOHN PETER	President & CEO	P Buy	2019-04-11	2019-04-18	100,000	$3.50	$350.0K	280,228	SEC↗
Kitchener Gregory David	Chief Financial Officer	A Award deriv	2019-02-26	2019-02-28	25,000	—	$0	25,000	SEC↗
Grais Linda S	Director	A Award deriv	2019-01-14	2019-01-16	25,000	—	$0	25,000	SEC↗
WILSON TROY EDWARD	Director	A Award deriv	2019-01-02	2019-07-18	1,500	—	$0	1,500	SEC↗
XANTHOPOULOS KLEANTHIS G	Director	A Award deriv	2019-01-02	2019-07-18	1,500	—	$0	1,500	SEC↗
GREATHOUSE KENNETH	Director	A Award deriv	2019-01-02	2019-07-18	1,500	—	$0	1,500	SEC↗
ELMS STEVE	Director, 10% Owner	A Award deriv	2019-01-02	2019-07-18	1,500	—	$0	1,500	SEC↗
Hagan Joseph P	Director	A Award deriv	2019-01-02	2019-07-18	1,500	—	$0	1,500	SEC↗
Kitchener Gregory David	Chief Financial Officer	A Award deriv	2018-10-15	2018-10-16	100,000	—	$0	100,000	SEC↗
WALKER JOHN PETER	President and CEO	A Award deriv	2018-05-31	2018-06-01	100,000	—	$0	100,000	SEC↗
WALKER JOHN PETER	President and CEO	A Award deriv	2018-05-31	2018-06-01	300,000	—	$0	300,000	SEC↗
KELLERMAN DONALD J	VP, Clinical Dev & Med Affai	A Award deriv	2018-05-31	2018-06-01	100,000	—	$0	100,000	SEC↗
Lewis Hayley	Senior VP, Operations	A Award deriv	2018-05-31	2018-06-01	100,000	—	$0	100,000	SEC↗
GREATHOUSE KENNETH	Director	A Award deriv	2018-05-31	2018-06-01	25,000	—	$0	25,000	SEC↗
Hagan Joseph P	Director	A Award deriv	2018-05-31	2018-06-01	25,000	—	$0	25,000	SEC↗
WILSON TROY EDWARD	Director	A Award deriv	2018-05-31	2018-06-01	25,000	—	$0	25,000	SEC↗
XANTHOPOULOS KLEANTHIS G	Director	A Award deriv	2018-05-31	2018-06-01	25,000	—	$0	25,000	SEC↗
ELMS STEVE	Director, 10% Owner	A Award deriv	2018-05-17	2018-05-21	25,000	—	$0	25,000	SEC↗
Kazma Gerald J	10% Owner	S Sale	2018-02-27	2018-02-28	80,880	$8.36	$676.2K	175,211	SEC↗
Kazma Gerald J	10% Owner	S Sale	2018-02-27	2018-02-28	5,901	$8.26	$48.7K	0	SEC↗
Kazma Gerald J	10% Owner	S Sale	2018-02-26	2018-02-28	1,500	$11.00	$16.5K	256,091	SEC↗
XANTHOPOULOS KLEANTHIS G	Director	A Award deriv	2018-01-02	2018-03-02	30,000	—	$0	30,000	SEC↗
Hagan Joseph P	Director	A Award deriv	2018-01-02	2018-03-02	30,000	—	$0	30,000	SEC↗
WILSON TROY EDWARD	Director	A Award deriv	2018-01-02	2018-03-02	30,000	—	$0	30,000	SEC↗
GREATHOUSE KENNETH	Director	A Award deriv	2018-01-02	2018-03-02	30,000	—	$0	30,000	SEC↗
GREATHOUSE KENNETH	Director	P Buy	2017-12-06	2017-12-08	55,000	$0.61	$33.5K	200,000	SEC↗
GREATHOUSE KENNETH	Director	P Buy	2017-12-01	2017-12-04	50,000	$0.62	$31.0K	145,000	SEC↗
GREATHOUSE KENNETH	Director	P Buy	2017-11-30	2017-12-04	45,000	$0.62	$27.9K	95,000	SEC↗
GREATHOUSE KENNETH	Director	P Buy	2017-11-15	2017-11-16	15,000	$0.58	$8.7K	50,000	SEC↗
GREATHOUSE KENNETH	Director	P Buy	2017-11-14	2017-11-16	35,000	$0.64	$22.4K	35,000	SEC↗
GREATHOUSE KENNETH	Director	A Award deriv	2017-10-03	2017-10-05	60,000	—	$0	60,000	SEC↗
WALKER JOHN PETER	President and CEO	A Award deriv	2017-08-09	2017-08-11	300,000	—	$0	300,000	SEC↗
WALKER JOHN PETER	President and CEO	D To issuer	2017-08-09	2017-08-11	26,666	—	$0	180,228	SEC↗
Lewis Hayley	Senior VP, Operations	A Award deriv	2017-05-31	2018-04-27	180,000	—	$0	180,000	SEC↗
KELLERMAN DONALD J	VP, Clinical Dev & Med Affai	A Award deriv	2017-05-31	2018-04-27	180,000	—	$0	180,000	SEC↗
WALKER JOHN PETER	Interim CEO	P Buy	2017-05-25	2017-05-25	37,550	$1.37	$51.4K	206,894	SEC↗
Erbez Georgia	CFO and Chief Business Offic	P Buy	2017-05-25	2017-05-25	68,000	$1.32	$89.8K	115,750	SEC↗
WALKER JOHN PETER	Interim CEO	P Buy	2017-05-25	2017-05-26	37,550	$1.37	$51.4K	206,894	SEC↗
WALKER JOHN PETER	Interim CEO	P Buy	2017-05-24	2017-05-25	36,166	$1.34	$48.5K	169,344	SEC↗
WALKER JOHN PETER	Interim CEO	P Buy	2017-05-24	2017-05-26	36,166	$1.34	$48.5K	169,344	SEC↗
WALKER JOHN PETER	Interim CEO	A Award	2017-05-18	2017-05-22	60,000	—	$0	133,178	SEC↗
WALKER JOHN PETER	Director	M Exercise deriv	2017-05-04	2017-05-08	9,478	—	$0	0	SEC↗
WALKER JOHN PETER	Director	M Exercise	2017-05-04	2017-05-08	9,478	—	$0	73,178	SEC↗
Tso Winnie Wing-Kei	Chief Financial Officer	A Award deriv	2017-04-10	2017-04-12	3,500	—	$0	17,500	SEC↗
Lewis Hayley	VP, Reg Affairs & Quality	A Award deriv	2017-04-10	2017-04-12	15,000	—	$0	15,000	SEC↗
KELLERMAN DONALD J	VP, Clinical Dev & Med Affai	A Award deriv	2017-04-10	2017-04-12	15,000	—	$0	15,000	SEC↗
Alataris Konstantinos	President, CEO	M Exercise deriv	2017-03-20	2017-03-22	127,389	—	$0	0	SEC↗
Alataris Konstantinos	President, CEO	M Exercise	2017-03-20	2017-03-22	127,389	$1.45	$184.7K	254,778	SEC↗
NEA 12 GP, LLC	10% Owner	S Sale	2017-02-13	2017-02-14	1,099,996	$2.01	$2.21M	952,809	SEC↗
BARRETT M JAMES	10% Owner	S Sale	2017-02-13	2017-02-14	1,099,996	$2.01	$2.21M	952,809	SEC↗
Hagan Joseph P	Director	A Award deriv	2016-11-02	2016-11-04	20,000	—	$0	20,000	SEC↗
WALKER JOHN PETER	Director	A Award deriv	2016-11-02	2016-11-04	30,000	—	$0	30,000	SEC↗
XANTHOPOULOS KLEANTHIS G	Director	A Award deriv	2016-11-02	2016-11-04	20,000	—	$0	20,000	SEC↗
WILSON TROY EDWARD	Director	A Award deriv	2016-11-02	2016-11-04	20,000	—	$0	20,000	SEC↗
SANDELL SCOTT D	10% Owner	S Sale	2016-09-16	2016-09-20	7,471	$0.75	$5.6K	2,052,805	SEC↗
BARRETT M JAMES	10% Owner	S Sale	2016-09-16	2016-09-20	7,471	$0.75	$5.6K	2,052,805	SEC↗
NEA Partners 12, Limited Partn	10% Owner	S Sale	2016-09-13	2016-09-15	10,000	$0.74	$7.4K	2,060,276	SEC↗
BARRETT M JAMES	10% Owner	S Sale	2016-09-13	2016-09-15	10,000	$0.74	$7.4K	2,060,276	SEC↗
Erbez Georgia	CBO and Interim CFO	A Award deriv	2016-09-07	2016-09-09	252,000	—	$0	252,000	SEC↗
BASKETT FOREST	10% Owner	S Sale	2016-08-29	2016-08-31	50,000	$1.01	$50.5K	2,070,276	SEC↗
BARRETT M JAMES	10% Owner	S Sale	2016-08-29	2016-08-31	50,000	$1.01	$50.5K	2,070,276	SEC↗
BASKETT FOREST	10% Owner	S Sale	2016-08-24	2016-08-26	1,200	$1.21	$1.5K	2,120,276	SEC↗
BARRETT M JAMES	10% Owner	S Sale	2016-08-24	2016-08-26	1,200	$1.21	$1.5K	2,120,276	SEC↗
XANTHOPOULOS KLEANTHIS G	Director	P Buy deriv	2016-08-19	2016-08-22	15,920	$0.13	$2.1K	15,920	SEC↗
XANTHOPOULOS KLEANTHIS G	Director	P Buy deriv	2016-08-19	2016-08-22	15,920	$0.13	$2.1K	15,920	SEC↗
Alataris Konstantinos	President, CEO	P Buy deriv	2016-08-19	2016-08-22	127,389	$0.13	$16.6K	127,389	SEC↗
Alataris Konstantinos	President, CEO	P Buy deriv	2016-08-19	2016-08-22	127,389	$0.13	$16.6K	127,389	SEC↗
WALKER JOHN PETER	Director	P Buy deriv	2016-08-19	2016-08-22	63,700	$0.13	$8.3K	63,700	SEC↗
WALKER JOHN PETER	Director	P Buy deriv	2016-08-19	2016-08-22	63,700	$0.13	$8.3K	63,700	SEC↗
KELLERMAN DONALD J	VP, Clinical Dev & Med Affai	P Buy deriv	2016-08-19	2016-08-22	15,920	$0.13	$2.1K	15,920	SEC↗
KELLERMAN DONALD J	VP, Clinical Dev & Med Affai	P Buy deriv	2016-08-19	2016-08-22	15,920	$0.13	$2.1K	15,920	SEC↗
Lewis Hayley	VP, Reg Affairs & Quality	P Buy deriv	2016-08-19	2016-08-22	4,775	$0.13	$621	4,775	SEC↗
Lewis Hayley	VP, Reg Affairs & Quality	P Buy deriv	2016-08-19	2016-08-22	4,775	$0.13	$621	4,775	SEC↗
Erbez Georgia	Interim CFO	P Buy deriv	2016-08-19	2016-08-22	47,750	$0.13	$6.2K	47,750	SEC↗
Erbez Georgia	Interim CFO	P Buy deriv	2016-08-19	2016-08-22	47,750	$0.13	$6.2K	47,750	SEC↗
XANTHOPOULOS KLEANTHIS G	Director	P Buy	2016-08-19	2016-08-22	15,920	$1.32	$21.0K	21,920	SEC↗
Alataris Konstantinos	President, CEO	P Buy	2016-08-19	2016-08-22	127,389	$1.32	$168.2K	127,389	SEC↗
WALKER JOHN PETER	Director	P Buy	2016-08-19	2016-08-22	63,700	$1.32	$84.1K	63,700	SEC↗
KELLERMAN DONALD J	VP, Clinical Dev & Med Affai	P Buy	2016-08-19	2016-08-22	15,920	$1.32	$21.0K	15,920	SEC↗
Lewis Hayley	VP, Reg Affairs & Quality	P Buy	2016-08-19	2016-08-22	4,775	$1.32	$6.3K	4,775	SEC↗
Erbez Georgia	Interim CFO	P Buy	2016-08-19	2016-08-22	47,750	$1.32	$63.0K	47,750	SEC↗
NEA 12 GP, LLC	10% Owner	S Sale	2016-07-21	2016-07-21	8,989	$1.33	$12.0K	2,121,476	SEC↗
BARRETT M JAMES	10% Owner	S Sale	2016-07-21	2016-07-21	8,989	$1.33	$12.0K	2,121,476	SEC↗
NEA 12 GP, LLC	10% Owner	S Sale	2016-07-20	2016-07-21	14,158	$1.24	$17.6K	2,130,465	SEC↗
BARRETT M JAMES	10% Owner	S Sale	2016-07-20	2016-07-21	14,158	$1.24	$17.6K	2,130,465	SEC↗
NEA 12 GP, LLC	10% Owner	S Sale	2016-07-19	2016-07-21	534	$1.17	$625	2,144,623	SEC↗
BARRETT M JAMES	10% Owner	S Sale	2016-07-19	2016-07-21	534	$1.17	$625	2,144,623	SEC↗
NEA Partners 12, Limited Partn	10% Owner	S Sale	2016-07-13	2016-07-15	13,382	$1.20	$16.1K	2,145,157	SEC↗
BARRETT M JAMES	10% Owner	S Sale	2016-07-13	2016-07-15	13,382	$1.20	$16.1K	2,145,157	SEC↗
Tso Winnie Wing-Kei	Chief Financial Officer	A Award deriv	2016-06-30	2016-07-01	14,000	—	$0	14,000	SEC↗
Scharin Eric	VP, Engineering & Operations	A Award deriv	2016-06-30	2016-07-01	3,750	—	$0	3,750	SEC↗
WALKER JOHN PETER	Director	A Award deriv	2016-05-04	2016-05-06	9,478	—	$0	9,478	SEC↗
WALKER JOHN PETER	Director	A Award deriv	2016-05-04	2016-05-06	6,813	—	$0	6,813	SEC↗
Tso Winnie Wing-Kei	Chief Financial Officer	A Award deriv	2016-03-29	2016-03-30	15,000	—	$0	15,000	SEC↗
Alataris Konstantinos	President, CEO	A Award deriv	2016-02-03	2016-02-04	200,000	—	$0	200,000	SEC↗
Alataris Konstantinos	President	D To issuer deriv	2015-12-15	2015-12-16	48,896	—	$0	0	SEC↗
Alataris Konstantinos	President	D To issuer deriv	2015-12-15	2015-12-16	160,498	—	$0	0	SEC↗
Alataris Konstantinos	President	A Award deriv	2015-12-15	2015-12-16	209,394	—	$0	209,394	SEC↗
Peri Laxmi	Sr. Vice President, Operatio	D To issuer deriv	2015-12-15	2015-12-16	40,000	—	$0	0	SEC↗
Peri Laxmi	Sr. Vice President, Operatio	A Award deriv	2015-12-15	2015-12-16	40,000	—	$0	40,000	SEC↗
Alataris Konstantinos	President	D To issuer deriv	2015-12-15	2015-12-17	48,896	—	$0	0	SEC↗
Alataris Konstantinos	President	D To issuer deriv	2015-12-15	2015-12-17	160,498	—	$0	0	SEC↗
Alataris Konstantinos	President	A Award deriv	2015-09-21	2015-10-01	160,498	—	$0	209,394	SEC↗
Alataris Konstantinos	President	A Award deriv	2015-09-21	2015-10-01	48,896	—	$0	48,896	SEC↗
Hagan Joseph P	Director	A Award deriv	2015-05-22	2015-05-27	28,000	—	$0	28,000	SEC↗
Peri Laxmi	Sr. Vice President, Operatio	A Award deriv	2015-05-22	2015-05-27	40,000	—	$0	40,000	SEC↗
XANTHOPOULOS KLEANTHIS G	Director	A Award	2015-04-01	2015-04-02	6,000	—	$0	6,000	SEC↗
WILSON TROY EDWARD	Director	A Award	2015-04-01	2015-04-02	3,000	—	$0	3,000	SEC↗
BioMed Realty L P	10% Owner	C Conversion deriv	2015-01-30	2015-02-02	1,101,393	—	$0	0	SEC↗
BioMed Realty L P	10% Owner	C Conversion deriv	2015-01-30	2015-02-02	337,150	—	$0	0	SEC↗
BioMed Realty L P	10% Owner	C Conversion deriv	2015-01-30	2015-02-02	717,437	—	$0	0	SEC↗
BioMed Realty L P	10% Owner	C Conversion deriv	2015-01-30	2015-02-02	1,148,956	—	$0	0	SEC↗
BioMed Realty L P	10% Owner	C Conversion deriv	2015-01-30	2015-02-02	267,446	—	$0	0	SEC↗
DRANT RYAN D	10% Owner	C Conversion deriv	2015-01-30	2015-02-02	0	—	$0	0	SEC↗
DRANT RYAN D	10% Owner	C Conversion deriv	2015-01-30	2015-02-02	0	—	$0	0	SEC↗
DRANT RYAN D	10% Owner	C Conversion deriv	2015-01-30	2015-02-02	0	—	$0	0	SEC↗
BARRETT M JAMES	Director, 10% Owner	C Conversion deriv	2015-01-30	2015-02-02	0	—	$0	0	SEC↗
BARRETT M JAMES	Director, 10% Owner	C Conversion deriv	2015-01-30	2015-02-02	0	—	$0	0	SEC↗
BARRETT M JAMES	Director, 10% Owner	C Conversion deriv	2015-01-30	2015-02-02	0	—	$0	0	SEC↗
BioMed Realty L P	10% Owner	C Conversion	2015-01-30	2015-02-02	64,661	$9.35	$604.6K	518,904	SEC↗
BioMed Realty L P	10% Owner	C Conversion	2015-01-30	2015-02-02	317,409	$9.35	$2.97M	1,896,982	SEC↗
BioMed Realty L P	10% Owner	P Buy	2015-01-30	2015-02-02	26,543	$11.00	$292.0K	545,447	SEC↗
DRANT RYAN D	10% Owner	P Buy	2015-01-30	2015-02-02	23,457	$11.00	$258.0K	2,158,539	SEC↗
DRANT RYAN D	10% Owner	C Conversion	2015-01-30	2015-02-02	341,201	$9.35	$3.19M	2,135,082	SEC↗
BARRETT M JAMES	Director, 10% Owner	P Buy	2015-01-30	2015-02-02	23,457	$11.00	$258.0K	2,158,539	SEC↗
BARRETT M JAMES	Director, 10% Owner	C Conversion	2015-01-30	2015-02-02	341,201	$9.35	$3.19M	2,135,082	SEC↗